CVS (CVS)

We offer a mix of high-yielders and companies with strong dividend-growth prospects.

In a world of muted economic growth, investors can expect modest gains and more volatility. But the bull lives on.

But plenty of risks remain for investors in the new year.

It's been a soap opera, but the pharmacy chain's proposed merger with Caremark could lead to a prosperous marriage.

This drugstore chain is on track for robust earnings growth, and its stock looks attractive, one analyst says.